about
Retinal Capillary Rarefaction in Patients with Type 2 Diabetes MellitusA randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation.Updated ESH position paper on interventional therapy of resistant hypertension.International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension.Low dose-eplerenone treatment decreases aortic stiffness in patients with resistant hypertension.SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial.The impact of age on the benefits and risks of aliskiren treatment: analyses of the 3A registry.2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).2013 ESH/ESC Guidelines for the management of arterial hypertensionEarly vascular parameters in the micro- and macrocirculation in type 2 diabetesHow does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trialEffects of the nitric oxide synthase inhibitor ronopterin (VAS203) on renal function in healthy volunteersEffects of renal denervation on blood pressure in hypertensive patients with end-stage renal disease: a single centre experiencePatient preference for therapies in hypertension: a cross-sectional survey of German patients
P50
Q36217523-B7826D02-25E1-45A4-84F7-A6F80D24396CQ36288929-B8C2D09C-41FF-4DAE-B168-AD3561CA2F33Q38111585-89955168-8E4D-40D8-8399-DEA4FC28CCB8Q38135985-FC24F45A-7FE4-4508-BCB7-D46B0E4A0512Q38955652-229F42ED-9777-47F7-A984-C658A9CED921Q47095186-A828FF4A-6567-4825-BD8F-E260698FC9B6Q48265147-63F1A9C5-1E2D-4A9D-A9F2-2EE2F718AC2AQ55057254-458B1DAA-D423-45CC-99A2-3ED0CF69FBB3Q56970511-61A97E73-4F02-4EC2-B551-81B12ED5820DQ58719212-C6A9BB1E-0B1A-41F9-82FC-68A1702087B8Q64101440-2BD5A2E5-0377-4B8C-9D56-487ACF78738CQ91151184-D0D977AF-D3AD-4AA7-8732-DE3A378A20F1Q91732982-A54BF96F-08C4-40C1-9C20-4E5668F09B0DQ92806895-DB2C5D45-C340-4D68-B2FF-A30261A97A6C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Roland E. Schmieder
@ast
Roland E. Schmieder
@en
Roland E. Schmieder
@es
Roland E. Schmieder
@nl
type
label
Roland E. Schmieder
@ast
Roland E. Schmieder
@en
Roland E. Schmieder
@es
Roland E. Schmieder
@nl
prefLabel
Roland E. Schmieder
@ast
Roland E. Schmieder
@en
Roland E. Schmieder
@es
Roland E. Schmieder
@nl
P244
P106
P21
P214
20148207864800342071
P244
n2016190020
P31
P496
0000-0003-2356-5883
P735
P7859
lccn-n2016190020